Plasma Kallikrein Inhibitor class drugs
3 results
Kalbitor (ecallantide)
(Ecallantide)Takeda Pharmaceuticals America, Inc.
Usage: KALBITOR® (ecallantide) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
Orladeyo (berotralstat hydrochloride)
(Berotralstat hydrochloride)BioCryst Pharmaceuticals Inc.
Usage: ORLADEYO® is indicated for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients aged 12 and older. It is not approved for treating acute HAE attacks, and doses exceeding 150 mg daily are not recommended due to potential QT prolongation risks.
Takhzyro (lanadelumab-flyo)
(lanadelumab-flyo)Takeda Pharmaceuticals America, Inc.
Usage: TAKHZYRO® is indicated for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients aged 2 years and older.